| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NMAT3434 |
| P698 | PubMed publication ID | 23001226 |
| P2093 | author name string | C Jeffrey Brinker | |
| P2860 | cites work | Recent advances with liposomes as pharmaceutical carriers | Q29616702 |
| Nanotechnology in drug delivery and tissue engineering: from discovery to applications | Q34112647 | ||
| Nanoparticles that communicate in vivo to amplify tumour targeting | Q34193793 | ||
| Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves | Q35049783 | ||
| Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. | Q35641963 | ||
| The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. | Q35779648 | ||
| Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy | Q36696647 | ||
| Transforming growth factor-beta and the immune response: implications for anticancer therapy | Q36944384 | ||
| Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer | Q37182719 | ||
| The polarization of immune cells in the tumour environment by TGFbeta | Q37454364 | ||
| Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line | Q37507270 | ||
| CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer | Q40327394 | ||
| Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15 | Q85179310 | ||
| P433 | issue | 10 | |
| P921 | main subject | nanoparticle | Q61231 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 831-832 | |
| P577 | publication date | 2012-10-01 | |
| P1433 | published in | Nature Materials | Q1998645 |
| P1476 | title | Nanoparticle immunotherapy: Combo combat | |
| P478 | volume | 11 |
| Q37625459 | Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles |
| Q35201530 | Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles |
| Q37666077 | Gold nanoparticle mediated cancer immunotherapy |
| Q90649853 | Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease |
| Q38984857 | Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma |
| Q93200030 | Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer |
Search more.